“We are no longer at a place where those with mental illness and addiction are hidden and ignored, b...

In patients with treatment-resistant depression who responded to intranasal esketamine plus an antid...

APA has endorsed the Mental Health Parity Compliance Act, a bipartisan bill introduced in the Senate...

There is a wealth of evidence that methylphenidate can improve attention-deficit/hyperactivity disor...

People who take antidepressants after age 60 may face a greater risk of dementia than those who don’...

Yesterday the Food and Drug Administration (FDA) approved Vraylar (cariprazine) for the treatment of...

People with obsessive-compulsive disorder (OCD) who don’t achieve adequate relief from medication an...

The final day of APA’s Annual Meeting featured an animated, case-based session on ECT and a review o...

Welcome to San Francisco! APA’s 2019 Annual Meeting began in San Francisco Saturday. From now throug...